EX-FILING FEES 4 tm2318498d1_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107.1

 

Calculation of Filing Fee Table

 

Form S-8

(Form Type)

 

Amicus Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type
  Security Class Title   Fee
Calculation
Rule
    Amount
Registered
(1)
    Proposed
Maximum
Offering
Price Per
Unit
    Maximum
Aggregate Offering
Price
    Fee Rate     Amount of
Registration
Fee
 
Equity   Common Stock, $0.01 par value per share, reserved for issuance pursuant to the 2023 Employee Stock Purchase Plan     457 (h)      2,850,000     $ 12.47 (2)   $ 35,539,500       0.0001102     $ 3,916.45  
Equity   Common Stock, $0.01 par value per share, reserved for issuance pursuant to the Amended and Restated 2007 Equity Incentive Plan     457 (h)      5,000,000     $ 12.47 (2)   $ 62,350,000       0.0001102     $ 6,870.97  
    Total Offering Amounts             7,850,000             $ 97,889,500             $ 10,787.42  
    Total Fee Offsets                                              
    Net Fee Due                                           $ 10,787.42  

 

(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that become issuable under either the 2023 Employee Stock Purchase Plan or the Amended and Restated 2007 Equity Incentive Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock.

 

(2) Estimated in accordance with Rule 457(h)(1) under the Securities Act solely for purposes of calculating the registration fee, based on the average of the high and low sales prices for the common stock as reported on the NASDAQ Global Market on June 7, 2023.